Factors associated with COVID-19-related death using OpenSAFELY EJ Williamson, AJ Walker, K Bhaskaran, S Bacon, C Bates, CE Morton, ... Nature 584 (7821), 430-436, 2020 | 5705 | 2020 |
OpenSAFELY: factors associated with COVID-19 death in 17 million patients EJ Williamson, AJ Walker, K Bhaskaran, S Bacon, C Bates, CE Morton, ... Nature 584 (7821), 430, 2020 | 694 | 2020 |
OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients OpenSAFELY Collaborative, E Williamson, AJ Walker, K Bhaskaran, ... MedRxiv, 2020.05. 06.20092999, 2020 | 646 | 2020 |
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational … R Mathur, CT Rentsch, CE Morton, WJ Hulme, A Schultze, B MacKenna, ... The Lancet 397 (10286), 1711-1724, 2021 | 405 | 2021 |
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the … A Schultze, AJ Walker, B MacKenna, CE Morton, K Bhaskaran, JP Brown, ... The Lancet Respiratory Medicine 8 (11), 1106-1120, 2020 | 280 | 2020 |
Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February DJ Grint, K Wing, E Williamson, HI McDonald, K Bhaskaran, D Evans, ... Eurosurveillance 26 (11), 2100256, 2021 | 219 | 2021 |
Opioid prescribing trends and geographical variation in England, 1998–2018: a retrospective database study HJ Curtis, R Croker, AJ Walker, GC Richards, J Quinlan, B Goldacre The Lancet Psychiatry 6 (2), 140-150, 2019 | 211 | 2019 |
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts AYS Wong, B MacKenna, CE Morton, A Schultze, AJ Walker, K Bhaskaran, ... Annals of the rheumatic diseases 80 (7), 943-951, 2021 | 113 | 2021 |
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform EJ Williamson, HI McDonald, K Bhaskaran, AJ Walker, S Bacon, S Davy, ... bmj 374, 2021 | 109 | 2021 |
Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY HJ Curtis, P Inglesby, CE Morton, B MacKenna, A Green, W Hulme, ... British Journal of General Practice 72 (714), e51-e62, 2022 | 101 | 2022 |
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY AJ Walker, B MacKenna, P Inglesby, L Tomlinson, CT Rentsch, HJ Curtis, ... British Journal of General Practice 71 (712), e806-e814, 2021 | 96 | 2021 |
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform B MacKenna, NA Kennedy, A Mehrkar, A Rowan, J Galloway, ... The Lancet Rheumatology 4 (7), e490-e506, 2022 | 94 | 2022 |
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England H Forbes, CE Morton, S Bacon, HI McDonald, C Minassian, JP Brown, ... bmj 372, 2021 | 93 | 2021 |
Severity of severe acute respiratory system coronavirus 2 (SARS-CoV-2) alpha variant (B. 1.1. 7) in England DJ Grint, K Wing, C Houlihan, HP Gibbs, SJW Evans, E Williamson, ... Clinical Infectious Diseases 75 (1), e1120-e1127, 2022 | 88 | 2022 |
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus … CT Rentsch, NJ DeVito, B MacKenna, CE Morton, K Bhaskaran, JP Brown, ... The Lancet Rheumatology 3 (1), e19-e27, 2021 | 67 | 2021 |
Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY OpenSAFELY Collaborative, B MacKenna, HJ Curtis, CE Morton, ... MedRxiv, 2021.01. 25.21250356, 2021 | 63 | 2021 |
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65 A Schultze, E Nightingale, D Evans, W Hulme, A Rosello, C Bates, ... The Lancet Regional Health–Europe 14, 2022 | 51 | 2022 |
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records EMF Horne, WJ Hulme, RH Keogh, TM Palmer, EJ Williamson, ... bmj 378, 2022 | 46 | 2022 |
Ethnic differences in COVID-19 infection, hospitalisation, and mortality: an OpenSAFELY analysis of 17 million adults in England OpenSAFELY Collaborative, R Mathur, CT Rentsch, CE Morton, ... MedRxiv, 2020.09. 22.20198754, 2020 | 40 | 2020 |
Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care R Croker, AJ Walker, B Goldacre Journal of Antimicrobial Chemotherapy 74 (4), 1125-1132, 2019 | 34 | 2019 |